This study continues our earlier findings on the hematopoiesis-modulating effects of adenosine A1 and A3 receptor agonists that were performed on committed hematopoietic progenitor and precursor cell populations. In the earlier experiments, N (6)-cyclopentyladenosine (CPA), an adenosine A1 receptor agonist, was found to inhibit proliferation in the above-mentioned hematopoietic cell systems, whereas N (6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide (IB-MECA), an adenosine A3 receptor agonist, was found to stimulate it. The topic of this study was to evaluate the possibility that the above-mentioned adenosine receptor agonists modulate the behavior of early hematopoietic progenitor cells and hematopoietic stem cells. Flow cytometric analysis of hematopoietic stem cells in mice was employed, as well as a functional test of hematopoietic stem and progenitor cells (HSPCs). These techniques enabled us to study the effect of the agonists on both short-term repopulating ability and long-term repopulating ability, representing multipotent progenitors and hematopoietic stem cells, respectively. In a series of studies, we did not find any significant effect of adenosine agonists on HSPCs in terms of their numbers, proliferation, or functional activity. Thus, it can be concluded that CPA and IB-MECA do not significantly influence the primitive hematopoietic stem and progenitor cell pool and that the hematopoiesis-modulating action of these adenosine receptor agonists is restricted to more mature compartments of hematopoietic progenitor and precursor cells.

Laboratory of Experimental Hematology Institute of Biophysics vvi Academy of Sciences of the Czech Republic Brno Czech Republic

See more in PubMed

Metcalf D. Hematopoietic regulators: redundancy or subtlety? Blood. 1993;82:3515–3523. PubMed

Abbracchio MP. P1 and P2 receptors in cell growth and differentiation. Drug Dev Res. 1998;39:396–406.

Abbracchio MP, Burnstock G. Purinergic signalling: pathophysiological roles. Jpn J Pharmacol. 1998;78:113–145. doi: 10.1254/jjp.78.113. PubMed DOI

Poulsen S-A, Quinn RJ. Adenosine receptors: new opportunities for future drugs. Bioorg Med Chem. 1998;6:619–641. doi: 10.1016/S0968-0896(98)00038-8. PubMed DOI

Schulte G, Fredholm BB. Signalling from adenosine receptor to mitogen-activated protein kinases. Cell Signal. 2003;15:813–827. doi: 10.1016/S0898-6568(03)00058-5. PubMed DOI

Klotz K-A. Adenosine receptors and their ligands. Naunyn-Schmiedeberg’s Arch Pharmacol. 2000;362:364–374. doi: 10.1007/s002100000315. PubMed DOI

Jacobson MA. Adenosine receptor agonists. Expert Opin Ther Patents. 2002;12:489–501. doi: 10.1517/13543776.12.4.489. DOI

Hofer M, Pospíšil M. Role of adenosine signaling in hematopoiesis—a short review. Med Hypotheses Res. 2006;3:629–635.

Hofer M, Pospisil M, Weiterova L, Hoferova Z. The role of adenosine receptor agonists in regulation of hematopoiesis. Molecules. 2011;16:675–685. doi: 10.3390/molecules16010675. PubMed DOI PMC

Pospíšil M, Hofer M, Netíková J, Pipalová I, Vacek A, Bartoníčková A, Volenec K. Elevation of extracellular adenosine induces radioprotective effects in mice. Radiat Res. 1993;134:323–330. doi: 10.2307/3578192. PubMed DOI

Pospíšil M, Hofer M, Znojil V, Vácha J, Netíková J, Holá J. Radioprotection of mouse hemaopoiesis by dipyridamole and adenosine monophosphate in fractionated treatment. Radiat Res. 1995;142:16–22. doi: 10.2307/3578962. PubMed DOI

Pospíšil M, Hofer M, Znojil V, Vácha J, Netíková J, Holá J. Synergistic effect of granulocyte colony-stimulating factor and drugs elevating extracellular adenosine on neutrophil production in mice. Blood. 1995;86:3692–3697. PubMed

Pospíšil M, Hofer M, Vacek A, Netíková J, Holá J, Znojil V, Weiterová L. Drugs elevating extracellular adenosine enhance cell cycling of hematopoietic progenitor cells as inferred from the cytotoxic effects of 5-fluorouracil. Exp Hematol. 2001;29:557–562. doi: 10.1016/S0301-472X(01)00622-1. PubMed DOI

Hofer M, Pospíšil M, Weiterová L, Znojil V, Vácha J, Holá J, Vacek A, Pipalová I. Combination of drugs elevating extracellular adenosine with granulocyte colony-stimulating factor promotes granulopoietic recovery after 5-fluorouracil treatment in mice. Physiol Res. 2001;50:521–524. PubMed

Pospíšil M, Hofer M, Vacek A, Znojil V, Pipalová I. Effects of stable adenosine receptor agonists on bone marrow hematopoietic cells as inferred from the cytotoxic action of 5-fluorouracil. Physiol Res. 2004;53:549–556. PubMed

Harrison DE, Zhong RK, Jordan CT, Lemischka IR, Astle CM. Relative to adult marrow, fetal liver repopulates nearly five times more effectively long-term than short-term. Exp Hematol. 1997;25:293–297. PubMed

Hofer M, Pospíšil M, Znojil V, Holá J, Štreitová D, Vacek A. Homeostatic action of adenosine A3 and A1 receptor agonists on proliferation of hematopoietic precursor cells. Exp Biol Med. 2008;233:897–900. doi: 10.3181/0802-RM-43. PubMed DOI

Hofer M, Pospíšil M, Vacek A, Holá J, Znojil V, Weiterová L, Štreitová D. Effects of adenosine A3 receptor agonist on bone marrow granulocytic system in 5-fluorouracil-treated mice. Eur J Pharmacol. 2006;538:163–167. doi: 10.1016/j.ejphar.2006.03.042. PubMed DOI

Michalová J, Savvulidi F, Šefc L, Faltusová K, Forgáčová K, Nečas E. Hematopoietic stem cells survive circulation arrest and reconstitute hematopoiesis in myeloablated mice. Biol Blood Marrow Transplant. 2011;17:1273–1281. doi: 10.1016/j.bbmt.2011.07.007. PubMed DOI

Kiel MJ, Yilmaz OH, Iwashita T, Terhorst C, Morrison SJ. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell. 2005;121:1109–1121. doi: 10.1016/j.cell.2005.05.026. PubMed DOI

Akashi K, Weissman IL (2001) Stem cells and hematolymphoid development. In: Zon LI, ed. Hematopoiesis. A Developmental Approach. Oxford: Oxford University Press 15-34

Šefc L, Pšenák O, Sýkora V, Šulc K, Nečas E. Response of hematopoiesis to cyclophosphamide follows highly specific patterns in bone marrow and spleen. J Hematother Stem Cell Res. 2003;12:47–62. doi: 10.1089/152581603321210136. PubMed DOI

Li CL, Johnson GR. Murine hematopoietic stem and progenitor cells: I. Enrichment and biologic characterization. . Blood. 1995;85:1472–1499. PubMed

Christensen JL, Weissman IL. Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells. Proc Natl Acad Sci USA. 2001;98:14541–14546. doi: 10.1073/pnas.261562798. PubMed DOI PMC

Hofer M, Pospíšil M, Znojil V, Holá J, Vacek A, Štreitová D. Adenosine A3 receptor agonist acts as a homeostatic regulator of bone marrow hematopoiesis. Biomed Pharmacother. 2007;61:356–359. doi: 10.1016/j.biopha.2007.02.010. PubMed DOI

Pospíšil M, Hofer M, Vacek A, Holá J, Pipalová I, Znojil V. N6-Cyclopentyladenosine inhibits proliferation of haematopoietic progenitor cells in vivo. Eur J Pharmacol. 2005;507:1–6. doi: 10.1016/j.ejphar.2004.11.027. PubMed DOI

Štreitová D, Šefc L, Savvulidi F, Pospíšil M, Holá J, Hofer M. Adenosine A1, A2a, A2b, and A3 receptors in hematopoiesis. 1. Expression of receptor mRNA in four mouse hematopoietic precursor cells. Physiol Res. 2010;59:133–137. PubMed

Hofer M, Dušek L, Hoferová Z, Stixová L, Pospíšil M. Expression of mRNA for adenosine A1, A2a, A2b, and A3 receptors in HL-60 cells: dependence on cell cycle phases. Physiol Res. 2011;60:913–920. PubMed

Enhanced survival of lethally irradiated adenosine A3 receptor knockout mice. A role for hematopoietic growth factors?

Lack of adenosine A3 receptors causes defects in mouse peripheral blood parameters